PMV Pharmaceuticals, Inc.
PMVP
$1.38
$0.042.61%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 79.43M | 93.55M | 112.94M | 129.25M | 142.27M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.98M | 2.23M | 2.28M | 3.20M | 3.04M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 81.41M | 95.78M | 115.23M | 132.45M | 145.31M |
|
|
|||||
| Total Current Assets | 81.41M | 95.78M | 115.23M | 132.45M | 145.31M |
| Net Property, Plant & Equipment | 363.00K | 486.00K | 1.04M | 1.15M | 1.26M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 296.00K | 296.00K | 297.00K | 249.00K | 248.00K |
| Total Assets | 82.07M | 96.56M | 116.56M | 133.84M | 152.86M |
|
|
|||||
| Total Accounts Payable | 2.02M | 1.63M | 3.16M | 3.40M | 2.60M |
| Total Accrued Expenses | 8.33M | 6.67M | 7.86M | 8.52M | 8.63M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 217.00K | 293.00K | 403.00K | 390.00K | 377.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 10.57M | 8.60M | 11.42M | 12.30M | 11.61M |
|
|
|||||
| Total Current Liabilities | 10.57M | 8.60M | 11.42M | 12.30M | 11.61M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | 435.00K | 541.00K | 643.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 10.57M | 8.60M | 11.85M | 12.85M | 12.25M |
|
|
|||||
| Common Stock & APIC | 554.16M | 552.47M | 551.08M | 549.33M | 547.94M |
| Retained Earnings | -482.58M | -464.49M | -446.45M | -428.42M | -407.36M |
| Treasury Stock & Other | -82.00K | -15.00K | 84.00K | 91.00K | 21.00K |
| Total Common Equity | 71.50M | 87.97M | 104.71M | 121.00M | 140.61M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 71.50M | 87.97M | 104.71M | 121.00M | 140.61M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 71.50M | 87.97M | 104.71M | 121.00M | 140.61M |
|
|
|||||